bit.bio

📍 Cambridge, United Kingdom🗓 Founded 2016👥 166 employees💰 Last funded Jan 2022
Biotechnology Research🌐 bit.bio
Website LinkedIn
bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines. Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies. To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision. Collaboration is at the heart of bit.bio. Join us on our journey. For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks
7
Total investors
1
Early stage
4
Mid stage
2
Late stage
2016
Founded

Investors

7 investors
All
Early stage
Mid stage
Late stage
Investor geography4 countries
United States
3
United Kingdom
2
Germany
1
Austria
1
Investor activity2016–2022 · investors recorded per year
20161201912021320222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in bit.bio?
bit.bio has 7 investors on record on gritt.io, including 1 early-stage backers, 4 mid-stage and 2 late-stage investors.
When did bit.bio last raise funding?
The most recent investment in bit.bio recorded on gritt.io was in January 2022.
When was bit.bio founded?
bit.bio was founded in 2016.
What industry is bit.bio in?
bit.bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is bit.bio based?
bit.bio is headquartered in Cambridge, United Kingdom.